Mineralys Therapeutics, Inc. (MLYS)
NASDAQ·Healthcare·Biotechnology
$26.10
-3.37%
Mkt Cap $1.91B
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 12, 2026 | — | — | — | -$0.52 | -$0.40 | +22.52% | — | — |
| Q4 2025 Nov 10, 2025 | — | — | — | -$0.66 | -$0.52 | +21.21% | — | — |
| Q3 2025 Aug 12, 2025 | — | — | — | -$0.78 | -$0.66 | +15.38% | — | — |
| Q2 2025 May 12, 2025 | — | — | — | -$1.02 | -$0.79 | +22.55% | — | — |
| Q1 2025 Feb 12, 2025 | — | — | — | -$1.00 | -$0.98 | +2.00% | — | — |
| Q4 2024 Nov 11, 2024 | — | — | — | -$0.83 | -$1.13 | -36.14% | — | — |
| Q3 2024 Aug 13, 2024 | — | — | — | -$0.73 | -$0.83 | -13.70% | — | — |
| Q2 2024 May 9, 2024 | — | — | — | -$0.68 | -$0.70 | -2.94% | — | — |
| Q1 2024 Mar 21, 2024 | — | — | — | -$0.85 | -$0.61 | +28.24% | — | — |
| Q4 2023 Nov 7, 2023 | — | — | — | -$0.72 | -$0.57 | +20.83% | — | — |
| Q3 2023 Aug 7, 2023 | — | — | — | -$0.83 | -$0.31 | +62.65% | — | — |
| Q2 2023 May 15, 2023 | — | — | — | -$0.71 | -$0.51 | +28.17% | — | — |
| Q1 2023 Mar 15, 2023 | — | — | — | $1.72 | -$1.74 | -201.16% | — | — |
| Q1 2023 Feb 10, 2023 | — | — | — | — | -$1288.84 | — | — | — |
| Q2 2022 Jun 30, 2022 | — | — | — | — | -$0.35 | — | — | — |
| Q1 2022 Mar 31, 2022 | — | — | — | — | -$0.41 | — | — | — |
| Q4 2021 Dec 31, 2021 | — | — | — | — | -$0.18 | — | — | — |